Literature DB >> 1415177

35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.

N D Mehta, A L Hooberman, E E Vokes, S Neeley, S Cotler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1415177     DOI： 10.1002/ajh.2830410215

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

2.  Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

Authors:  Alyssa M Morimoto; Donna Thibault Flesher; Jihong Yang; Kristen Wolslegel; Xiangdan Wang; Ann Brady; Alexander R Abbas; Valerie Quarmby; Eric Wakshull; Bruce Richardson; Michael J Townsend; Timothy W Behrens
Journal:  Arthritis Rheum       Date:  2011-08

Review 3.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 4.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

Authors:  Timothy B Niewold; William I Swedler
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 3.650

5.  Systemic lupus erythematosus following acute lymphocytic leukemia.

Authors:  Sulaiman M Al Mayouf; Amal Seraihy
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.